A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Steel, Craig ^a   van der Gaag, Mark ^b   Korrelboom, Kees ^c   Simon, Judit ^d   Phiri, Peter ^e   Baksh, M Fazil ^a   Wykes, Til ^f   Rose, Diana ^f   Rose, Suzanna ^g   Hardcastle, Mark ^g   Enright, Simon ^g   Evans, Gareth ^g   Kingdon, David ^h  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c PsyQ   (Netherlands)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e SOUTHERN HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE SEVERITY; DSM-5; HUMAN; MULTICENTER STUDY; OUTCOME ASSESSMENT; POSITIVE MEMORY TRAINING; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SINGLE BLIND PROCEDURE; UNITED KINGDOM; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; DEPRESSIVE DISORDER; FEMALE; MALE; MEMORY; METHODOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; DEPRESSIVE DISORDER; ENGLAND; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; RESEARCH DESIGN; SCHIZOPHRENIA; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84928565441     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0453-6     Document Type: Article

References (29)

1. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ. 2007;10:23-41.
2. NICE. Schizophrenia; Full National Clinical Guideline on Core Interventions in Primary and Secondary Care. London: Gaskell Press; 2009. Updated guideline.
3. Buckley P, Miller B, Lehrer D, Castle D. Psychiatric co-morbidities and schizophrenia. Schizophr Bull. 2009;35:383-402.
4. Palmer BA, Pankrantz S, Bostwick MD. The lifetime risk of suicide in schizophrenia: a re-examination. Arch Gen Psychiatry. 2005;62:247-53.
5. Whitehead C, Moss S, Cardno A, Lewis G, Furtado VA. Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst Rev. 2002. (2). Art. No.: CD002305. doi:10.1002/14651858.CD002305.
6. Butler AC, Chapman J, Forman E, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev. 2006;26:17-31.
7. Jacobson NS, Martell CR, Dimidjian S. Behavioral activation treatment for depression: returning to contextual roots. Clin Psychol Sci Pract. 2001;8:255-70.
8. Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K, et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol. 2008;76:966-78.
9. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34:523-37.
10. Brewin CR. Understanding cognitive behaviour therapy: a retrieval competition account. Behav Res Ther. 2006;44:765-84.
11. Korrelboom K, de Jong M, Huijbrechts I, Daansen P. Competitive Memory Training (COMET) for treating low self-esteem in patients with eating disorders: a randomized clinical trial. J Consult Clin Psychol. 2009;77:974-80.
12. Korrelboom K, Marissen M, van Assendelft T. Competitive Memory Training for low self-esteem in patients with personality disorders: a randomized effectiveness study. Behav Cogn Psychother. 2011;39:1-11.
13. Korrelboom K, van der Weele K, Gjaltema M, Hoogstraten C. Competitive memory training (COMET) for treating low self-esteem: a pilot study in a routine clinical setting. Behav Therapist. 2009;32:3-8.
14. Korrelboom K, Maarsingh M, Huijbrechts I. Competitive Memory Training (COMET) for treating low self esteem in patients with depressive disorders; a randomized clinical trial. Depress Anxiety. 2012;29:102-10.
15. van der Gaag M, van Oosterhout B, Daalman K, Sommer IE, Korrelboom K. Initial evaluation of the effects of competitive memory training (COMET) on depression in schizophrenia-spectrum patients with persistent auditory verbal hallucinations: a randomized controlled trial. Br J Clin Psychol. 2012;51(2):158-71.
16. Haddock G, McCarron J, Tarrier N, Faragher E, Tarrier N. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879-89.
17. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory. 2nd ed. San Antonia, Texas: The Psychological Corporation; 1996.
18. Rosenberg M. Society and the adolescent self-image. Princeton, NJ: Princeton University Press; 1965.
19. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13:261-76.
20. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7.
21. Mundt JC, Marks IM, Shear MK, Greist JH. The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461-4.
22. Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:1-13.
23. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
24. University of Birmingham. ICECAP-A. http://www.birmingham.ac.uk/research/activity/mds/projects/HaPS/HE/ICECAP/ICECAP-A/index.aspx.
25. Simon J, Anand P, Gray A, Rugkasa J, Yeeles K, Burns T. Operationalising the capabilities approach for outcome measurement in mental health research. Soc Sci Med. 2013;98:187-96.
26. Sen A. Choice, welfare and measurement. Cambridge, MA: Harvard University Press; 1982.
27. University of Birmingham. CES. http://www.birmingham.ac.uk/research/activity/mds/projects/HaPS/HE/ICECAP/CES/index.aspx.
28. Beecham J, Knapp M. Costing psychiatric interventions. In Measuring Mental Health Needs (2nd edn) (ed. G. Thornicroft), 2001. pp. 200-4. Gaskell.
29. Clarke PM, Wolstenholme JL, Wordsworth S. Applied Methods of Cost-effectiveness Analysis in Healthcare (Band 3 von Handbooks in Health Economic Evaluation). Oxford, UK: Oxford University Press; 2010.